BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 16583187)

  • 21. Skin lesions simulating chronic dermatomyositis during long-term hydroxyurea therapy.
    Richard M; Truchetet F; Friedel J; Leclech C; Heid E
    J Am Acad Dermatol; 1989 Oct; 21(4 Pt 1):797-9. PubMed ID: 2808796
    [No Abstract]   [Full Text] [Related]  

  • 22. Gottron's papules exhibit dermal accumulation of CD44 variant 7 (CD44v7) and its binding partner osteopontin: a unique molecular signature.
    Kim JS; Bashir MM; Werth VP
    J Invest Dermatol; 2012 Jul; 132(7):1825-32. PubMed ID: 22456539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydroxyurea dermopathy: a unique lichenoid eruption complicating long-term therapy with hydroxyurea.
    Daoud MS; Gibson LE; Pittelkow MR
    J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):178-82. PubMed ID: 9039164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Bilateral ankle ulcers associated with hydroxyurea therapy for chronic myelogenous leukemia].
    Masuoka H; Kobayashi M; Kaito K; Yoshida M; Sekita T; Saeki A; Nishiwaki K; Shimada T; Ochiai S; Ootsubo H
    Rinsho Ketsueki; 1995 Feb; 36(2):156-8. PubMed ID: 7715088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydroxyurea dermopathy with a dermatomyositis-like eruption and a large leg ulcer.
    Suehiro M; Kishimoto S; Wakabayashi T; Ikeuchi A; Miyake H; Takenaka H; Okano A; Hirai H; Shimazaki C; Yasuno H
    Br J Dermatol; 1998 Oct; 139(4):748-9. PubMed ID: 9892930
    [No Abstract]   [Full Text] [Related]  

  • 26. The evolution of hydroxyurea therapy in chronic myelogenous leukemia.
    Kennedy BJ
    Semin Oncol; 1992 Jun; 19(3 Suppl 9):21-6. PubMed ID: 1641653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Longitudinal melanonychia and hydroxyurea].
    Pirard C; Michaux JL; Bourlond A
    Ann Dermatol Venereol; 1994; 121(2):106-9. PubMed ID: 7979014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dermatomyositis-like eruption induced by hydroxyurea: a case report.
    Janerowicz D; Czarnecka-Operacz M; Stawny M; Silny W
    Acta Dermatovenerol Alp Pannonica Adriat; 2009 Sep; 18(3):131-4. PubMed ID: 19784527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversible leg ulcer due to hydroxyurea in a case of chronic myeloid leukemia.
    Tripathi AK; Ahmad R; Sawlani KK
    J Assoc Physicians India; 2003 Oct; 51():1014-5. PubMed ID: 14719596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dermatomyositis-like eruption after long-term hydroxyurea therapy for polycythemia vera.
    Oskay T; Kutluay L; Ozyilkan O
    Eur J Dermatol; 2002; 12(6):586-8. PubMed ID: 12459535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydroxyurea-induced fever in a patient with chronic myelogenous leukemia.
    Tsurumi H; Goto H; Hara T; Moriwaki H
    Int J Hematol; 2000 Oct; 72(3):386-7. PubMed ID: 11186000
    [No Abstract]   [Full Text] [Related]  

  • 32. [Anhidrosis during long-term hydroxyurea therapy in a patient with chronic myelogenous leukemia].
    Takagi K; Nakamura T; Misaki H; Ueda T
    Rinsho Ketsueki; 2000 Nov; 41(11):1214-9. PubMed ID: 11193442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A case of juvenile dermatomyositis manifesting inflammatory epidermal nevus-like skin lesions: unrecognized cutaneous manifestation of blaschkitis?
    Takahashi Y; Murota H; Tarutani M; Sano S; Okinaga T; Tominaga K; Yano T; Katayama I
    Allergol Int; 2010 Dec; 59(4):425-8. PubMed ID: 20962570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple skin tumors in long-term treatment with hydroxyurea.
    Stasi R; Cantonetti M; Abruzzese E; Papi M; Didona B; Cavalieri R; Papa G
    Eur J Haematol; 1992 Feb; 48(2):121-2. PubMed ID: 1547876
    [No Abstract]   [Full Text] [Related]  

  • 35. Hydroxyurea-induced dermatomyositis koebnerizing at the site of previous shingles.
    Veraitch O; Curto-Garcia N; Harrison C; Stefanato CM; McGibbon D
    Clin Exp Dermatol; 2019 Jul; 44(5):546-548. PubMed ID: 30411394
    [No Abstract]   [Full Text] [Related]  

  • 36. Hydroxyurea-induced hypersensitivity pneumonitis: A case report and literature review.
    Sandhu HS; Barnes PJ; Hernandez P
    Can Respir J; 2000; 7(6):491-5. PubMed ID: 11121094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hydroxyurea-related leg ulcers in a patient with chronic myelogenous leukemia: a case report and review of the literature.
    Kato N; Kimura K; Yasukawa K; Yoshida K
    J Dermatol; 1999 Jan; 26(1):56-62. PubMed ID: 10063214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A fatal presentation of dermatomyositis with facial swelling.
    Dwivedi N; Michael C; Lew DB; Arnold S; Igarashi M; Bertorini T; Thompson JW; Myers LK; Brown ML
    Int J Pediatr Otorhinolaryngol; 2012 May; 76(5):745-9. PubMed ID: 22376996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ulcerative lichen planus-like dermatitis due to long-term hydroxyurea therapy.
    Bohn J; Hansen JP; Menné T
    J Eur Acad Dermatol Venereol; 1998 Mar; 10(2):187-9. PubMed ID: 9553923
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of chemotherapy (busulfan-hydroxyurea) and interferon-alfa on bone marrow morphologic features in chronic myelogenous leukemia. Histochemical and morphometric study on sequential trephine biopsy specimens with special emphasis on dynamic features.
    Thiele J; Kvasnicka HM; Schmitt-Graeff A; Bundschuh S; Biermann T; Roessler G; Wasmus M; Diehl V; Zankovich R; Schaefer HE
    Am J Clin Pathol; 2000 Jul; 114(1):57-65. PubMed ID: 10884800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.